Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-07 | Mr. Matthew C. BuschCAO & VP of Finance | -41.00 | 13.58k | Sale to Issuer | 331.11 | 3.15k | -1.29% |
| 2026-05-07 | Mr. Esteban SantosExec. VP of Operations | -522.00 | 172.84k | Sale to Issuer | 331.11 | 75.32k | -0.69% |
| 2026-05-07 | Dr. David M. ReeseExec. VP & CTO | -556.00 | 184.10k | Sale to Issuer | 331.11 | 33.24k | -1.64% |
| 2026-05-07 | Mr. Derek MillerSVP of HR | -151.00 | 50.00k | Sale to Issuer | 331.11 | 9.86k | -1.51% |
| 2026-05-07 | Ms. Rachna KhoslaSVP of Business Development | -93.00 | 30.79k | Sale to Issuer | 331.11 | 6.88k | -1.33% |
| 2026-05-07 | Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO | -88.00 | 29.14k | Sale to Issuer | 331.11 | 5.96k | -1.46% |
| 2026-05-07 | Mr. Peter H. GriffithExec. VP & CFO | -556.00 | 184.10k | Sale to Issuer | 331.11 | 40.13k | -1.37% |
| 2026-05-07 | Mr. Jonathan P. GrahamExec. VP, General Counsel & Secretary | -499.00 | 165.22k | Sale to Issuer | 331.11 | 31.65k | -1.55% |
| 2026-05-07 | Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy | -615.00 | 203.63k | Sale to Issuer | 331.11 | 40.84k | -1.48% |
| 2026-05-07 | Mr. Robert A. BradwayChairman & CEO | -2.08k | 688.38k | Sale to Issuer | 331.11 | 620.48k | -0.33% |
| 2026-05-07 | Dr. James E. BradnerEVP of Research & Development, Artificial Intelligence and Data | -446.00 | 147.68k | Sale to Issuer | 331.11 | 7.10k | -5.91% |
| 2026-05-06 | Dr. James E. BradnerEVP of Research & Development, Artificial Intelligence and Data | -407.00 | 134.14k | Sale to Issuer | 329.59 | 6.60k | -5.81% |
| 2026-05-06 | Mr. Robert A. BradwayChairman & CEO | -1.70k | 560.96k | Sale to Issuer | 329.59 | 618.61k | -0.27% |
| 2026-05-06 | Mr. Matthew C. BuschCAO & VP of Finance | -50.00 | 16.48k | Sale to Issuer | 329.59 | 3.08k | -1.60% |
| 2026-05-06 | Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy | -502.00 | 165.45k | Sale to Issuer | 329.59 | 40.29k | -1.23% |
| 2026-05-06 | Mr. Jonathan P. GrahamExec. VP, General Counsel & Secretary | -408.00 | 134.47k | Sale to Issuer | 329.59 | 31.20k | -1.29% |
| 2026-05-06 | Mr. Peter H. GriffithExec. VP & CFO | -502.00 | 165.45k | Sale to Issuer | 329.59 | 39.63k | -1.25% |
| 2026-05-06 | Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO | -76.00 | 25.05k | Sale to Issuer | 329.59 | 5.88k | -1.28% |
| 2026-05-06 | Ms. Rachna KhoslaSVP of Business Development | -79.00 | 26.04k | Sale to Issuer | 329.59 | 6.80k | -1.15% |
| 2026-05-06 | Mr. Derek MillerSVP of HR | -123.00 | 40.54k | Sale to Issuer | 329.59 | 9.72k | -1.25% |
| 2026-05-06 | Dr. David M. ReeseExec. VP & CTO | -454.00 | 149.63k | Sale to Issuer | 329.59 | 32.75k | -1.37% |
| 2026-05-06 | Mr. Esteban SantosExec. VP of Operations | -427.00 | 140.73k | Sale to Issuer | 329.59 | 74.85k | -0.57% |
| 2026-05-02 | Mr. Esteban SantosExec. VP of Operations | -1.34k | 441.30k | Sale to Issuer | 329.82 | 74.44k | -1.77% |
| 2026-05-02 | Dr. David M. ReeseExec. VP & CTO | -1.43k | 472.63k | Sale to Issuer | 329.82 | 32.31k | -4.25% |
| 2026-05-02 | Mr. Derek MillerSVP of HR | -365.00 | 120.38k | Sale to Issuer | 329.82 | 9.61k | -3.66% |
| 2026-05-02 | Ms. Rachna KhoslaSVP of Business Development | -225.00 | 74.21k | Sale to Issuer | 329.82 | 6.72k | -3.24% |
| 2026-05-04 | Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO | -1.24k | 400.45k | 売り | 323.73 | 5.81k | -17.56% |
| 2026-05-02 | Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO | -242.00 | 79.82k | Sale to Issuer | 329.82 | 5.81k | -4.00% |
| 2026-05-02 | Mr. Peter H. GriffithExec. VP & CFO | -1.43k | 472.63k | Sale to Issuer | 329.82 | 39.16k | -3.53% |
| 2026-05-02 | Mr. Jonathan P. GrahamExec. VP, General Counsel & Secretary | -1.26k | 414.58k | Sale to Issuer | 329.82 | 30.81k | -3.92% |
| 2026-05-02 | Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy | -1.59k | 525.40k | Sale to Issuer | 329.82 | 39.81k | -3.85% |
| 2026-05-02 | Mr. Matthew C. BuschCAO & VP of Finance | -68.00 | 22.43k | Sale to Issuer | 329.82 | 2.99k | -2.22% |
| 2026-05-02 | Mr. Robert A. BradwayChairman & CEO | -5.06k | 1.67M | Sale to Issuer | 329.82 | 616.98k | -0.81% |
| 2026-03-16 | Mr. Esteban SantosExec. VP of Operations | -5.62k | 2.06M | Sale to Issuer | 366.21 | 73.37k | -7.12% |
| 2026-03-16 | Dr. David M. ReeseExec. VP & CTO | -6.02k | 2.21M | Sale to Issuer | 366.21 | 31.16k | -16.20% |
| 2026-03-16 | Mr. Derek MillerSVP of HR | -1.62k | 591.80k | Sale to Issuer | 366.21 | 9.31k | -14.78% |
| 2026-03-16 | Ms. Rachna KhoslaSVP of Business Development | -707.00 | 258.91k | Sale to Issuer | 366.21 | 6.54k | -9.75% |
| 2026-03-16 | Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO | -787.00 | 288.21k | Sale to Issuer | 366.21 | 6.86k | -10.29% |
| 2026-03-16 | Mr. Peter H. GriffithExec. VP & CFO | -5.75k | 2.10M | Sale to Issuer | 366.21 | 38.01k | -13.14% |
| 2026-03-16 | Mr. Jonathan P. GrahamExec. VP, General Counsel & Secretary | -5.35k | 1.96M | Sale to Issuer | 366.21 | 29.80k | -15.23% |
| 2026-03-16 | Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy | -6.69k | 2.45M | Sale to Issuer | 366.21 | 38.53k | -14.80% |
| 2026-03-16 | Mr. Robert A. BradwayChairman & CEO | -21.29k | 7.80M | Sale to Issuer | 366.21 | 612.90k | -3.36% |
| 2026-03-16 | Mr. Matthew C. BuschCAO & VP of Finance | -327.00 | 119.75k | Sale to Issuer | 366.21 | 2.89k | -10.17% |
| 2026-03-04 | Mr. Robert A. BradwayChairman & CEO | 35.50k | 5.55M | Derivative Exercise and Retained Stock | 156.35 | 633.62k | 5.93% |
| 2026-03-04 | Mr. Robert A. BradwayChairman & CEO | -84.29k | 18.79M | Derivative Exercise and Sale | 156.35 - 379.27 | 633.62k | - |
| 2026-02-26 | Mr. Esteban SantosExec. VP of Operations | -54.79k | 11.50M | Derivative Exercise and Sale | 162.60 - 379.12 | 68.16k | - |
| 2026-02-19 | Mr. Matthew C. BuschCAO & VP of Finance | -1,000.00 | 375.79k | 売り | 375.79 | 2.26k | -30.64% |
| 2026-02-09 | Dr. James E. BradnerEVP of Research & Development, Artificial Intelligence and Data | -3.10k | 1.19M | Sale to Issuer | 384.32 | 15.21k | -16.95% |
| 2025-11-20 | Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO | -3.14k | 525.98k | Derivative Exercise and Sale | 162.60 - 337.26 | 5.59k | - |
| 2025-11-12 | Ms. Rachna KhoslaSVP of Business Development | -890.00 | 299.26k | 売り | 336.24 | 5.04k | -15.02% |
| 2025-11-12 | Mr. Murdo GordonEVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy | -6.88k | 2.32M | 売り | 336.83 | 29.52k | -18.90% |
| 2025-11-11 | Dr. David M. ReeseExec. VP & CTO | -6.80k | 0.00 | Other Disposition | - | 23.90k | -22.15% |
| 2025-11-05 | Ms. Rachna KhoslaSVP of Business Development | -226.00 | 67.05k | Sale to Issuer | 296.70 | 6.02k | -3.62% |
| 2025-11-05 | Mr. Matthew C. BuschCAO & VP of Finance | -202.00 | 59.93k | Sale to Issuer | 296.70 | 3.11k | -6.10% |
| 2025-08-20 | Ms. Nancy A. GrygielSenior VP of Worldwide Compliance & Business Ethics and CCO | -1.27k | 376.28k | 売り | 296.99 | 5.58k | -18.51% |
| 2025-06-05 | Ms. Rachna KhoslaSVP of Business Development | -1.50k | 434.52k | 売り | 289.68 | 5.91k | -20.25% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
